Latest Can-Fite BioPharma News & Updates

See the latest news and media coverage for Can-Fite. We track all announcements, press releases, and industry mentions in real time, all in one place.

Company icon
Can-Fite BioPharma (Can-Fite)

Clinical-stage biopharmaceutical company developing oral drug candidates

canfite.com
Number of employees
9–10
Industry
Pharmaceuticals

Last updated

Latest news about Can-Fite BioPharma (Can-Fite)

In short: Can-Fite presented positive Phase IIa pancreatic cancer data and planned global licensing discussions.

Company announcements

Can-Fite

Can-Fite's Namodenoson meets safety endpoint in pancreatic cancer study

Median overall survival exceeded 5 months in third-line patients; one second-line patient alive over 18 months.

Unlock all announcements with a

Media coverage

Finanznachrichten

Can-Fite BioPharma Ltd.: Can-Fite Reports Positive Phase 2a Data with Namodenoson in Pancreatic Cancer; 35% of Patients Remain on Therapy, Including One Beyond 16 Months

Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE: CANF), a clinical-stage biotechnology company developing a pipeline of proprietary small molecule...

Unlock all articles with a

Never miss news about Can-Fite

Track Can-Fite and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.